A Multicenter, Open-Label, Single Arm, Long Term Extension Study of WA 19926 to Describe Safety During Treatment With Tocilizumab in Patients From Poland With Early, Moderate to Severe Rheumatoid Arthritis
Phase of Trial: Phase III
Latest Information Update: 11 Mar 2016
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Registrational
- Sponsors Roche
- 09 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2015 Status changed from completed to active, no longer recruiting as per ClinicalTrials.gov record.
- 19 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.